-
Signature
-
Donna Kalazdy, by power of attorney for Michael David Garrison
-
Issuer symbol
-
BDX
-
Transactions as of
-
18 Jul 2025
-
Net transactions value
-
-$207,401
-
Form type
-
4
-
Filing time
-
22 Jul 2025, 17:29:46 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Garrison Michael David |
EVP & President, Medical |
BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES |
Donna Kalazdy, by power of attorney for Michael David Garrison |
22 Jul 2025 |
0001944816 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BDX |
Common Stock |
Options Exercise |
$939,245 |
+6,360 |
+130% |
$147.68 |
11,247 |
18 Jul 2025 |
Direct |
|
| transaction |
BDX |
Common Stock |
Disposed to Issuer |
$933,001 |
-5,175 |
-46% |
$180.29 |
6,072 |
18 Jul 2025 |
Direct |
|
| transaction |
BDX |
Common Stock |
Sale |
$213,463 |
-1,184 |
-19% |
$180.29 |
4,888 |
18 Jul 2025 |
Direct |
|
| transaction |
BDX |
Common Stock |
Sale |
$182 |
-1 |
-0.02% |
$181.50 |
4,887 |
18 Jul 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BDX |
Stock Appreciation Rights |
Options Exercise |
$0 |
-6,360 |
-100% |
$0.000000 |
0 |
18 Jul 2025 |
Common Stock |
6,360 |
$147.68 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
The reported transactions were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2024.